RABEVIB DSR PLUS RABEPRAZOLE 40mg. IP + DOMPERIDONE 30mg. IP

Rabevib DSR Plus capsules combine Rabeprazole 40 mg and Domperidone 30 mg for acid reflux with nausea and bloating. Main uses: short-term healing and symptomatic relief of erosive or ulcerative gastroesophageal reflux disease (GERD); maintenance of healing of erosive or ulcerative GERD and reduction of heartburn relapse; treatment of symptomatic GERD with heartburn and acid regurgitation; nausea, vomiting, bloating and fullness linked to slow stomach emptying and dyspepsia.

Common side effects of Rabevib DSR Plus Capsule include headache; diarrhoea; nausea; vomiting; abdominal pain; flatulence. Get medical help at once if you notice acute tubulointerstitial nephritis (kidney inflammation); severe skin reactions or other signs of allergy, including swelling of the face or lips and breathing difficulty; low magnesium levels with long-term use.

Each Rabevib DSR Plus capsule contains Rabeprazole 40 mg + Domperidone 30 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Rabevib DSR Plus Capsule only as your doctor advises.

The MRP of Rabevib DSR Plus Capsule is ₹164.06 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹125 and the PTS is ₹112.5.

Each Rabevib DSR Plus capsule contains Rabeprazole 40 mg + Domperidone 30 mg. It comes in a pack of 10x10 (Alu Alu).

Inside the capsule, Rabeprazole acts on the acid pump present on the surface of the stomach lining cells and lowers the acid produced in the stomach, which allows inflamed tissue to settle and eases heartburn. Domperidone works on the gut wall and the brain's vomiting centre; it improves the forward movement of food through the stomach and helps control nausea, vomiting, bloating and a feeling of fullness caused by slow stomach emptying.

Must not be used by patients with a known allergy to rabeprazole, substituted benzimidazoles, domperidone or any other ingredient of the capsule, and must not be used with rilpivirine-containing products. Must not be used in moderate or severe liver impairment, or by patients with QT prolongation or significant cardiac conduction disorders. Must not be used together with QT-prolonging medicines or strong CYP3A4 inhibitors. Check with a doctor first if the patient is on warfarin or other blood thinners, as monitoring may be needed, and during pregnancy and breastfeeding. Check with a doctor first if the patient has kidney disease, mild liver problems or is on long-term therapy.

Rabevib DSR Plus Capsule is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.